Contact Us

Head Office
Protox Therapeutics Inc.
1210-885 West Georgia Street
Vancouver, BC Canada V6C 3E8
t: 604.688.0199
f: 604.688.0173
info@protoxtherapeutics.com

Map of Location

For Business Development inquiries, contact Tom D'orazio at:
business@protoxtherapeutics.com

For Investor inquiries, contact James Beesley at:
ir@protoxtherapeutics.com

For Clinical Trial inquiries, contact Nina Merchant at:
clinical@protoxtherapeutics.com

For all other inquiries,
info@protoxtherapeutics.com

Email Update
To receive the latest information about developments at Protox,
sign up here to be included on our email list.

NAME:         
EMAIL:  

What's New

May 15, 2008
Protox Doses First Patient In Phase 2 BPH Clinical Trial

May 13, 2008
Protox Reports 2008 First Quarter Results

May 5, 2008
Protox Announces Private Placement

April 30, 2008
Protox Announces Collaboration with FDA

 

Events

BioFinance
Toronto Marriott Eaton Centre Hotel (Trinity IV room) - Toronto, ON

When: May 7, 2008 10:30a.m. EDT

Presenter: Dr. Fahar Merchant, President & CEO

 

Stock Quote

LAST TRADE:$0.73
TRADE TIME:3:43PM EST
CHANGE:$-0.02 (-2.67%)
PREV CLOSE: $0.75
OPEN:$0.75
BID:$0.72
ASK:$0.73